|
|
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptomsKeywords: abdominal pain, constipation, functional gastrointestinal diseases, irritable bowel syndrome Abstract:
|